Evaluation of a Ionic Silver and Honey Preparation to Treat Chronic Wounds of the Lower Legs
NCT ID: NCT01111695
Last Updated: 2011-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
30 participants
INTERVENTIONAL
2010-01-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives are to evaluate the tolerance and side effects of the honey based preparation in the management of chronic wounds.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Honey and ionic silver dressing
ApisSept
honey and ionic silver based dressing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ApisSept
honey and ionic silver based dressing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic wounds due to arterial or venous insufficiency stages 1 to 3 and difficult to heal with the usual treatments and
* Written informed consent
Exclusion Criteria
* Patient suffering from mental disorder that may interfere with the treatment.
* Known allergy or intolerance to any of the products used in the formulation.
* Having received systemic antibiotics within 7 days of starting treatment with honey based formulation.
* Arterial insufficiency stage IV of the lower limbs.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haute école de santé - Genève
UNKNOWN
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Service de dermatologie - HUG
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Denis Salomon, Dr
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Home Care Service of the canton of Geneva
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CER 09-013
Identifier Type: -
Identifier Source: org_study_id